에서 실시간으로 운영 중이에요! 자세히 알아보기

Alphatec Holdings

ATEC

시가총액 US$16.2억

10.46 USD

-0.47

4.3%

장 마감 시점 업데이트됨 10월 16일 PM 4:00 EDT

프리마켓

시간외 거래

10.48

+0.02

0.19%

1일

-4.3%

5일

-2.15%

1개월

-0.38%

3개월

12.84%

6개월

-3.33%

연초 이후

-49.61%

1년

-26.65%

5년

-12.1%

10년

60.43%

소개: Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.

직원 수: 913

건강관리 의료기기

뉴스

긍정적

중립

부정적

투자 심리 3개월

긍정적 37.5%

중립 50%

부정적 12.5%

ATEC Appoints Tommy Carls Executive Vice President, Data Intelligence and Strategy

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced that Thomas "Tommy" Carls has joined the company as Executive Vice President, Data Intelligence and Strategy. Carls will report directly to Chairman and Chief Executive Officer, Pat Miles, and will serve as a member of ATEC's Senior Leadership Team. In this newly created role, Carls will lead ATEC'.

ATEC Appoints Tommy Carls Executive Vice President, Data Intelligence and Strategy

Zacks Investment Research

Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?

Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?

Alphatec: Straightening Its Back

Alphatec reports 15% revenue growth and improved operating leverage, with realistic break-even levels approaching despite ongoing net losses and dilution. Alphatec maintains $882 million in sales guidance and raises adjusted EBITDA guidance to $140 million, signaling confidence in margin improvements and operational progress. Leverage concerns are easing as free cash flow turns positive, dilution slows, and interest expenses decline, aided by strong EOS imaging technology growth.

Alphatec: Straightening Its Back

Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript

Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript

Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript

Zacks Investment Research

Alphatec (ATEC) Q2 Earnings Lag Estimates

Alphatec (ATEC) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.02 per share a year ago.

Alphatec (ATEC) Q2 Earnings Lag Estimates

Alphatec Q2 Earnings Call Highlights

Alphatec NASDAQ: ATEC reported second-quarter 2026 revenue of $214 million, up 15% from a year earlier, as growth in surgical procedures and surgeon adoption supported higher profitability and positive free cash flow.

Alphatec Q2 Earnings Call Highlights

ATEC Reports Second Quarter Financial Results

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2026, and business highlights. Second Quarter 2026 Financial Results Quarter Ended June 30, 2026 Total revenue $214 million GAAP gross margin 72.2% Non-GAAP gross margin 72.5% GAAP operating expenses $156 million Non-GAAP operating expenses $135 mill.

ATEC Reports Second Quarter Financial Results

ATEC Announces Participation in Upcoming Investor Conferences

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conference(s): Management will host one-on-one investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Monday, August 10, 2026. Management will present to investors at the 19th Annual Piper Sandler MedTech and Dia.

ATEC Announces Participation in Upcoming Investor Conferences

ATEC to Report Second Quarter 2026 Financial Results on August 4, 2026

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2026 financial results on August 4, 2026, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.WebcastTo access the live webcast, please use this link or visit the Investor Relations Events & Presentations section of ATEC's cor.

ATEC to Report Second Quarter 2026 Financial Results on August 4, 2026

Alphatec Holdings Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders

SAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Alphatec Holdings, Inc. (NASDAQ: ATEC) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws.

Alphatec Holdings Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders

뉴스 순위 보기

Lightweight Charts™를 사용해 가격 차트를 구현했어요.